Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic Challenges.
Journal: Transplantation and cellular therapy
Published: April 15, 2026
Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic Challenges.
Journal: Transplantation and cellular therapy
Published: April 15, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations.
Journal: Transplantation and cellular therapy
Published: January 20, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: January 13, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Blood cancer discovery
Published: January 04, 2026
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis.
Journal: Transplantation and cellular therapy
Published: October 11, 2025
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: September 03, 2025
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: September 03, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study.
Journal: The Lancet. Haematology
Published: June 24, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact.
Journal: Bone marrow transplantation
Published: June 21, 2025
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy.
Journal: Transplantation and cellular therapy
Published: April 24, 2025
Last Updated: 09/26/2026